Arrhythmogenesis in patients with stable chronic obstructive pulmonary disease

Journal of Cardiovascular Medicine

Volumn 9, Issue 1, 2008, Pages 89-93

  Theofilogiannakos, Efstratios K ^a   Anogeianaki, Antonia ^a   Tsekoura, Panagiota ^a   Glouftsios, Petros ^a   Ilonidis, George ^a   Hatzitolios, Apostolos ^a   Anogianakis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Arrhythmia; Autonomic nervous system; Chronic obstructive pulmonary disease; Electrocardiography; QT dispersion

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARRHYTHMOGENESIS; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HEART REPOLARIZATION; HUMAN; LUNG FUNCTION TEST; MALE; PARAMETER; QT DISPERSION; RR INTERVAL; SEX RATIO; STATISTICAL SIGNIFICANCE; ANOXIA; AUTONOMIC NERVOUS SYSTEM; BLOOD GAS ANALYSIS; DISEASE COURSE; HEART RATE; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; AGED; ANOXIA; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; BLOOD GAS ANALYSIS; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 40349096079     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328028fe73     Document Type: Article

References (34)

1. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 2003; 48:1185-1191.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
3. Faulkner MA, Hilleman DE. The economic impact of chronic obstructive pulmonary disease. Expert Opin Pharmacother 2002; 3:219-228.
4. Nishimura K, Tsukino M. Clinical course and prognosis of patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000; 6:127-132.
5. Sarubbi B, Esposito V, Ducceschi V, Meoli I, Grella E, Santangelo L, et al. Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy? Int J Cardiol 1997; 58:287-292.
6. Stewart AG, Waterhouse JC, Howard P. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med 1995; 89:79-84.
7. Wikipedia, the free encyclopedia. Coefficient of variation. http://en.wikipedia.org/wiki/Coefficient_of_variation. [Accessed 9 March 2007]
8. Reed GF, Lynn F, Meade BD. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 2002; 9:1235-1239.
9. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999; 354:1625-1633.
10. Macfarlane PW. Measurement of QT dispersion. Heart 1998; 80:421-423.
11. Gang Y, Guo XH, Crook R, Hnatkova K, Camm AJ, Malik M. Computerised measurements of QT dispersion in healthy subjects. Heart 1998; 80:459-466.
12. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36:1749-1766.
13. Yeragani VK, Tancer ME, Glitz D, Uhde T, Desai N. Significant difference in beat-to-beat QT interval variability among different leads. Heart Dis 2002; 4:344-348.
14. Bilchick KC, Berger RD. Heart rate variability. J Cardiovasc Electrophysiol 2006; 17:691-694.
15. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology the North American Society of Pacing and Electrophysiology. Circulation 1996; 93:1043-1065.
16. Rennard SI. COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 1998; 113 (Suppl):235S-241S.
17. Levine PA, Klein MD. Mechanisms of arrhythmias in chronic obstructive lung disease. Geriatrics 1976; 31:47-56.
18. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107:1514-1519.
19. Gorecka D. Cardiac arrhythmias in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1997; 52:278-281.
20. Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94:44-48.
21. Kiely DG, Cargill RI, Lipworth BJ. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109:1215-1221.
22. Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001; 96:517-527.
23. Sahu P, Lim PO, Rana BS, Struthers AD. QT dispersion in medicine: electrophysiological Holy Grail or fool's gold? QJM 2000; 93:425-431.
24. Sicouri C, Antzelevitch C. Electrophysiologic characteristics of M cells in the canine left ventricular free wall. J Cardiovasc Electrophysiol 1995; 6:591-603.
25. Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4:1207-1214.
26. Chhabra SK, De S. Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med 2005; 99:126-133.
27. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26:1553-1579.
28. Scalvini S, Porta R, Zanelli E, Volterrani M, Vitacca M, Pagani M, et al. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur Respir J 1999; 13:119-124.
29. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-262.
30. Casolo GC, Stroder P, Signorini C, Calzolari F, Zucchini M, Balli E, et al. Heart rate variability during the acute phase of myocardial infarction. Circulation 1992; 85:2073-2079.
31. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996; 27:1053-1060.
32. Stys A, Stys T. Current clinical applications of heart rate variability. Clin Cardiol 1998; 21:719-724.
33. Sevre K, Bendz B, Hanko E, Nakstad AR, Hauge A, Kasin JI, et al. Reduced autonomic activity during stepwise exposure to high altitude. Acta Physiol Scand 2001; 173:409-417.
34. Saito S, Tanobe K, Yamada M, Nishihara F. Relationship between arterial oxygen saturation and heart rate variability at high altitudes. Am J Emerg Med 2005; 23:8-12.